Dupont Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-418
| Closed | -$103K | – | 1596 |
|
|
2022
Q3 | $103K | Sell |
418
-104
| -20% | -$28.1K | 0.01% | 1025 |
|
|
2022
Q2 | $129K | Buy |
522
+136
| +35% | +$36.7K | 0.01% | 1132 |
|
|
2022
Q1 | $128K | Buy |
386
+71
| +23% | +$21.9K | 0.01% | 1213 |
|
|
2021
Q4 | $113K | Sell |
315
-169
| -35% | -$57.1K | ﹤0.01% | 1272 |
|
|
2021
Q3 | $158K | Buy |
+484
| New | +$164K | 0.01% | 1287 |
|
|
2021
Q2 | – | Sell |
-1,147
| Closed | -$366K | – | 1957 |
|
|
2021
Q1 | $366K | Buy |
+1,147
| New | +$367K | 0.01% | 1076 |
|
|
2020
Q4 | – | Sell |
-1,865
| Closed | -$517K | – | 1443 |
|
|
2020
Q3 | $517K | Sell |
1,865
-295
| -14% | -$85K | 0.01% | 742 |
|
|
2020
Q2 | $522K | Buy |
+2,160
| New | +$434K | 0.01% | 758 |
|
|
2019
Q2 | – | Sell |
-1,164
| Closed | -$332K | – | 1289 |
|
|
2019
Q1 | $332K | Sell |
1,164
-317
| -21% | -$105K | 0.01% | 918 |
|
|
2018
Q4 | $481K | Buy |
1,481
+954
| +181% | +$331K | 0.01% | 747 |
|
|
2018
Q3 | $237K | Sell |
527
-3,888
| -88% | -$1.53M | 0.01% | 852 |
|
|
2018
Q2 | $1.81M | Buy |
4,415
+3,862
| +698% | +$1.4M | 0.04% | 399 |
|
|
2018
Q1 | $161K | Buy |
+553
| New | +$140K | ﹤0.01% | 835 |
|
|
2017
Q4 | – | Sell |
-27,700
| Closed | -$4.67M | – | 1008 |
|
|
2017
Q3 | $4.67M | Buy |
27,700
+21,082
| +319% | +$3.19M | 0.11% | 192 |
|
|
2017
Q2 | $948K | Buy |
6,618
+2,412
| +57% | +$324K | 0.02% | 538 |
|
|
2017
Q1 | $527K | Hold |
4,206
| – | – | 0.01% | 682 |
|
|
2016
Q4 | $474K | Sell |
4,206
-843
| -17% | -$97.7K | 0.01% | 699 |
|
|
2016
Q3 | $649K | Sell |
5,049
-4,056
| -45% | -$486K | 0.01% | 536 |
|
|
2016
Q2 | $995K | Sell |
9,105
-836
| -8% | -$83.2K | 0.02% | 450 |
|
|
2016
Q1 | $943K | Buy |
9,941
+1,283
| +15% | +$108K | 0.02% | 458 |
|
|
2015
Q4 | $782K | Buy |
8,658
+2,751
| +47% | +$233K | 0.02% | 513 |
|
|
2015
Q3 | $548K | Hold |
5,907
| – | – | 0.01% | 524 |
|
|
2015
Q2 | $388K | Buy |
+5,907
| New | +$392K | 0.01% | 535 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Dupont Capital Management's ABMD Position: Q4 2022 in Review
Dupont Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 418 shares — an estimated $103K sold.
Dupont Capital Management first reported a position in ABMD in Q2 2015 and held it in 23 quarters. The position peaked at $4.67M in Q3 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Dupont Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Dupont Capital Management sold 418 Abiomed Inc shares in Q4 2022, an estimated $103K.
- Dupont Capital Management first reported a position in Abiomed Inc in Q2 2015 and held it in 23 quarters.
- Dupont Capital Management's Abiomed Inc position peaked at $4.67M in Q3 2017.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.